• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基层医疗中阿片类药物减量的障碍、促进因素和资源:澳大利亚全科医生的经验。

Barriers, facilitators, and resources to opioid deprescribing in primary care: experiences of general practitioners in Australia.

机构信息

Institute for Musculoskeletal Health, Sydney, NSW, Australia.

Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, NSW, Australia.

出版信息

Pain. 2022 Apr 1;163(4):e518-e526. doi: 10.1097/j.pain.0000000000002340.

DOI:10.1097/j.pain.0000000000002340
PMID:33990105
Abstract

Deprescribing is the systematic process of discontinuing drugs when harms outweigh the benefits. We conducted semistructured telephone interviews with 22 general practitioners (GPs) who had prescribed or deprescribed opioids in patients with chronic noncancer pain within the past 6 months to investigate the barriers and facilitators to deprescribing opioid analgesics in patients with chronic noncancer pain. We also explored GPs' perspectives on the available resources to assist them with opioid deprescribing. Interviews were audio-recorded, transcribed verbatim, and then coded using an iterative process until data saturation reached. The thematic analysis process identified themes, first as concepts, and then refined to overarching themes after the merging of similar subthemes. Themes exploring barriers to deprescribing highlighted the difficulties GPs face while considering patient factors and varying prescribing practices within the confines of the health system. Patient motivation and doctor-patient rapport were central factors to facilitate deprescribing and GPs considered the most important deprescribing resource to be a multidisciplinary network of clinicians to support themselves and their patients. Therefore, although GPs emphasised the importance of deprescribing opioid analgesics, they also expressed many barriers relating to managing complex pain conditions, patient factors, and varying prescribing practices between clinicians. Some of these barriers could be mitigated by GPs having time and resources to educate and build rapport with their patients. This suggests the need for further development of multimodal resources and improved support through the public health system to enable GPs to prioritise patient-centred care.

摘要

撤药是指当药物的危害超过益处时,系统地停止使用药物的过程。我们对半结构化电话采访了 22 名全科医生(GP),他们在过去 6 个月内为慢性非癌痛患者开处或撤处了阿片类药物,以调查在慢性非癌痛患者中撤处阿片类镇痛药的障碍和促进因素。我们还探讨了全科医生对现有资源的看法,以帮助他们进行阿片类药物撤药。采访进行了录音、逐字转录,然后使用迭代过程进行编码,直到达到数据饱和。主题分析过程确定了主题,首先是概念,然后在合并类似的子主题后细化为总体主题。撤药障碍主题强调了全科医生在考虑患者因素和在医疗体系限制内改变处方实践时面临的困难。患者动机和医患关系是促进撤药的关键因素,全科医生认为最重要的撤药资源是多学科临床医生网络,以支持自己和患者。因此,尽管全科医生强调了撤处阿片类镇痛药的重要性,但他们也表达了许多与管理复杂疼痛状况、患者因素和临床医生之间不同的处方实践有关的障碍。通过为全科医生提供教育和与患者建立融洽关系的时间和资源,这些障碍中的一些可以得到缓解。这表明需要进一步开发多模式资源,并通过公共卫生系统提供更好的支持,使全科医生能够优先考虑以患者为中心的护理。

相似文献

1
Barriers, facilitators, and resources to opioid deprescribing in primary care: experiences of general practitioners in Australia.基层医疗中阿片类药物减量的障碍、促进因素和资源:澳大利亚全科医生的经验。
Pain. 2022 Apr 1;163(4):e518-e526. doi: 10.1097/j.pain.0000000000002340.
2
Exploring the facilitators and barriers in opioid deprescribing for non-cancer pain treatment experienced by general practitioners: A qualitative study.探讨全科医生在非癌性疼痛治疗中减少阿片类药物使用的促进因素和障碍:一项定性研究。
Eur J Pain. 2024 Aug;28(7):1101-1115. doi: 10.1002/ejp.2243. Epub 2024 Jan 30.
3
Opioid deprescribing: Qualitative perspectives from those with chronic non-cancer pain.阿片类药物减用:慢性非癌痛患者的定性观点。
Res Social Adm Pharm. 2022 Dec;18(12):4083-4091. doi: 10.1016/j.sapharm.2022.07.043. Epub 2022 Aug 5.
4
Barriers and facilitators to opioid deprescribing among Advanced Nurse Practitioners: A qualitative interview study.高级执业护师在减少阿片类药物使用方面的障碍和促进因素:一项定性访谈研究。
J Adv Nurs. 2024 Jun;80(6):2500-2511. doi: 10.1111/jan.15995. Epub 2023 Dec 11.
5
Older Adult and Primary Care Practitioner Perspectives on Using, Prescribing, and Deprescribing Opioids for Chronic Pain.老年人和初级保健医生对使用、开处和停用阿片类药物治疗慢性疼痛的看法。
JAMA Netw Open. 2024 Mar 4;7(3):e241342. doi: 10.1001/jamanetworkopen.2024.1342.
6
General practitioners' insight into deprescribing for the multimorbid older individual: a qualitative study.全科医生对多病共存老年个体减药的见解:一项定性研究。
Int J Clin Pract. 2016 Mar;70(3):261-76. doi: 10.1111/ijcp.12780.
7
Challenges and Enablers of Deprescribing: A General Practitioner Perspective.减药的挑战与促进因素:全科医生视角
PLoS One. 2016 Apr 19;11(4):e0151066. doi: 10.1371/journal.pone.0151066. eCollection 2016.
8
Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis.阿片类药物减用的挑战和制定阿片类药物减用指南时需要考虑的因素:定性分析。
BMJ Qual Saf. 2021 Feb;30(2):133-140. doi: 10.1136/bmjqs-2020-010881. Epub 2020 Mar 27.
9
Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.监测和减少慢性非癌症疼痛阿片类镇痛药的障碍和促进因素:使用理论领域框架进行系统评价和定性证据综合。
BMJ Qual Saf. 2022 May;31(5):387-400. doi: 10.1136/bmjqs-2021-014186. Epub 2022 Jan 21.
10
"The lesser of two evils": a framework analysis of consumers' perspectives on opioid deprescribing and the development of opioid deprescribing guidelines.“两害相权取其轻”:对消费者对阿片类药物减用观点和阿片类药物减用指南制定的框架分析。
Pain. 2021 Nov 1;162(11):2686-2692. doi: 10.1097/j.pain.0000000000002270.

引用本文的文献

1
Community opioid dispensing after rib fracture injuries: CODI study.肋骨骨折损伤后的社区阿片类药物配药:CODI研究
Br J Pain. 2024 Nov 20:20494637241300264. doi: 10.1177/20494637241300264.
2
Older Adult and Primary Care Practitioner Perspectives on Using, Prescribing, and Deprescribing Opioids for Chronic Pain.老年人和初级保健医生对使用、开处和停用阿片类药物治疗慢性疼痛的看法。
JAMA Netw Open. 2024 Mar 4;7(3):e241342. doi: 10.1001/jamanetworkopen.2024.1342.
3
A digital health intervention to support patients with chronic pain during prescription opioid tapering: a pilot randomised controlled trial.
一项在处方阿片类药物减量期间支持慢性疼痛患者的数字健康干预措施:一项试点随机对照试验。
Pain Rep. 2024 Feb 12;9(2):e1128. doi: 10.1097/PR9.0000000000001128. eCollection 2024 Apr.
4
'It was a joint plan we worked out together'. How the I-WOTCH programme enabled people with chronic non-malignant pain to taper their opioids: a process evaluation.“这是我们一起制定的联合计划”。I-WOTCH 项目如何使慢性非恶性疼痛患者逐渐减少阿片类药物用量:过程评估。
BMJ Open. 2023 Dec 6;13(12):e074603. doi: 10.1136/bmjopen-2023-074603.
5
Clinical Observation, Management and Function Of low back pain Relief Therapies (COMFORT): A cluster randomised controlled trial protocol.临床观察、管理与下腰痛缓解治疗的作用(COMFORT):一项集群随机对照试验方案。
BMJ Open. 2023 Nov 21;13(11):e075286. doi: 10.1136/bmjopen-2023-075286.
6
Challenges in Deprescribing among Older Adults in Post-Acute Care Transitions to Home.老年患者在康复后过渡到居家阶段时,减少药物使用面临的挑战。
J Am Med Dir Assoc. 2024 Jan;25(1):138-145.e6. doi: 10.1016/j.jamda.2023.09.021. Epub 2023 Oct 29.
7
Understanding general practitioners' prescribing choices to patients with chronic low back pain: a discrete choice experiment.理解全科医生为慢性下背痛患者开处方的选择:离散选择实验。
Int J Clin Pharm. 2024 Feb;46(1):111-121. doi: 10.1007/s11096-023-01649-y. Epub 2023 Oct 26.
8
Re-thinking the perception of long-term opioid use in RMDs.重新思考对风湿性和肌肉骨骼疾病中长期使用阿片类药物的认知。
Nat Rev Rheumatol. 2023 Nov;19(11):678-679. doi: 10.1038/s41584-023-01022-3.
9
Pragmatic Delphi study aimed at determining practical components for a tool designed to assist Dutch primary care-givers in opioid deprescribing for non-cancer pain.实用德尔菲研究旨在确定一种工具的实用组成部分,该工具旨在帮助荷兰初级保健提供者减少非癌症疼痛的阿片类药物。
Fam Pract. 2023 Dec 22;40(5-6):827-843. doi: 10.1093/fampra/cmad058.